Agios Pharmaceuticals Inc... (AGIO)

NASDAQ: AGIO · Real-Time Price · USD

31.03

1.34 (4.51%)

At close: May 01, 2025, 3:59 PM

30.55

-1.55%

After-hours: May 01, 2025, 07:28 PM EDT

Agios Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	36.5M	26.82M	14.24M	n/a	203.2M	117.91M	94.39M	43.01M	69.89M
Cost of Revenue	4.17M	9.5M	1.7M	18.78M	2.81M	1.32M	1.4M	292.68M	220.16M
Gross Profit	32.33M	17.32M	12.54M	-18.78M	200.39M	116.59M	92.99M	-249.67M	-150.27M
Operating Income	-425.74M	-391.49M	-389.05M	-378.42M	-316.15M	-426.33M	-362.48M	-320.79M	-200.99M
Interest Income	48.08M	33.34M	12.79M	836K	6.61M	14.86M	16.45M	6.12M	2.51M
Pretax Income	717.97M	-352.09M	-231.8M	-356.51M	-327.37M	-411.47M	-346.03M	-314.67M	-198.47M
Net Income	673.73M	-352.09M	-74.56M	1.6B	-335.22M	-396.61M	-346.03M	-314.67M	-198.47M
Selling & General & Admin	156.78M	119.9M	121.67M	121.44M	149.07M	132.03M	114.14M	71.12M	50.71M
Research & Development	301.29M	288.9M	279.91M	256.97M	367.47M	410.89M	341.32M	292.68M	220.16M
Other Expenses	n/a	n/a	6.75M	14.43M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	458.07M	408.81M	401.58M	378.42M	516.54M	542.93M	455.47M	363.81M	270.88M
Interest Expense	n/a	n/a	12.79M	n/a	17.83M	n/a	16.45M	6.12M	2.51M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	462.24M	418.31M	403.29M	378.42M	519.35M	544.25M	456.87M	363.81M	270.88M
Income Tax Expense	44.24M	n/a	-157.25M	-1.98B	7.85M	-14.86M	32.9M	-6.43M	-5.71M
Shares Outstanding (Basic)	56.81M	55.65M	54.79M	60.45M	69M	59.99M	57.42M	46.59M	39.13M
Shares Outstanding (Diluted)	57.89M	55.65M	54.79M	60.45M	69M	59.99M	57.42M	46.59M	39.13M
EPS (Basic)	11.86	-6.33	-1.36	26.55	-4.86	-6.61	-6.03	-6.75	-5.07
EPS (Diluted)	11.64	-6.33	-1.36	26.55	-4.86	-6.61	-6.03	-6.75	-5.07
EBITDA	-420.08M	-384.86M	-380.48M	-337.73M	-326.13M	-394.85M	-338.86M	-314.36M	-195.28M
EBIT	-425.74M	-391.49M	-389.05M	-356.51M	-335.92M	-411.47M	-346.03M	-320.79M	-200.99M
Depreciation & Amortization	5.65M	6.62M	18.56M	18.78M	18.77M	16.62M	7.17M	6.43M	5.71M